and rate-corrected velocity of circumferential fiber shortening (Vcfc), which is independent of heart rate (HR) and loading conditions has previously been used to assess cardiac contractility in insulin dependent diabetes mellitus (IDDM). This study is the first report in which this relation has been utilized with data obtained by echocardiography in addition to the traditional indices, to evaluate the cardiac function in asymptomatic, middle-aged patients with noninsulin dependent diabetes mellitus (NIDDM) at baseline and during dobutamine stimulation.
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There were 16 NIDDM patients in our study and these patients were classified into 2 groups. Group 1 consisted of 11 patients without microvascular complications. Group 2 consisted of the remaining 5 patients with microvascular complications. Ten age-and sex-matched normal subjects were enrolled as a control group. At baseline, diabetic patients tended to have a faster HR and a greater LV enddiastolic dimension, though these values were not significantly different from the normal subjects. Ejection fraction (EF) in group 1 was signifi- ported to be abnormal.1-5) Usually, diastolic dysfunction precedes systolic dysfunction.1-3) Systolic function is usually normal at rest, and reveals an inadequate response to some stress conditions.4,5) These findings may form the basis of a clinical diagnosis of diabetic cardiomyopathy. Among the most widely used methods to assess systolic function are left ventricular ejection fraction (EF) at rest, and response to exercise as measured by radionuclide angiography or Doppler-echocardiography. However, EF, which is used as the ejection index of cardiac performance, depends on preload, afterload and heart rate (HR), in addition to ventricular contractility. Furthermore, EF response to exercise is influenced by the acute circulatory adjustment to exercise, including peripheral vasodilation and changes in cardiac autonomic tone. Any abnormality in these parameters could blunt the response of cardiac performance to exercise. Therefore, the increment of EF on exercise may not represent actual cardiac reserve.6) velocity of fiber shortening (Vcfc was used as a preload-and heart rate (HR)-independent index of contractility that incorporates afterload into the analysis.7,8) Therefore, this index is more appropriate than the traditional indices to evaluate the cardiac contractility. Nevertheless, only a few studies have assessed LV condiabetes (IDDM).6,9-12) The pathophysiology of type 2 diabetes (NIDDM), being insulin resistant, may be different from that of type 1 diabetes. Does this difference and subsequent abnormality affect the influence on ventricular contractility? A few reports which used the traditional ejection indices showed that cardiac function was even more impaired in NIDDM than in IDDM. 13, 14) The purpose of this study was to investigate the cardiac hemodynamics of a group of type 2 diabetic patients without clinical evidence of hypertensive, valvular or ischemic heart disease, by load-and HR-independent endsystolic indices at resting state and with dobutamine challenge.
SUBJECTS AND METHODS
There were 16 patients with NIDDM without known heart disease in our study. They had no history of angina pectoris. Their resting EGG had no changes indicating myocardial ischemia and their treadmill exercise tests were all negative. Group 1 consisted of the 11 patients without microvascular complications. The remaining 5 patients had microvascular complications including proteinuria or diabetic retinopathy, and were assigned to group 2. The mean normal subjects served as the control group. They had no history of angina pectoris and their treadmill exercise tests were all negative. The cardiac rhythms of the subjects in these 3 groups were all of sinus origin. Informed consent was obtained from all of the study subjects prior to the study. Left ventricular function was evaluated by echocardiography (Toshiba SSH-65A, Tokyo, Japan), together with the simultaneous recordings of ECG, continuous noninvasive blood pressure (BP) measurement at the right brachial site (Cortronic APM 770, NY, USA), phonography and indirect right carotid pulse tracing.
The subject was placed in the left oblique decubitus position. Two-dimen- 
RESULTS

Demographic
and laboratory data ( Table I) : The age and sex in the 3 groups were matched except that males predominated in group 2. The mean ages were around 50 years old. The duration of diabetes in group 2 was
The body mass index was similar in the 3 groups (p>0.05). The control of blood sugar was mildly inadequate in the diabetic patients, with HbA1c being ence (p>0.05 ). The cholesterol, triglyceride, BUN and creatinine levels in blood were all within normal limits and there was no significant difference in these levels between groups 1 and 2. Hemodynamic and echocardiographic values (Table II) : HR and BP at baseline and during dobutamine infusion were similar among the 3 groups , though there was a trend of faster HR in the diabetic patients at baseline. During dobutamine infusion, the systolic BP increased to 140mmHg in all patients and controls, and HR remained stable in normal subjects and in group 2, but slowed in group 1. Doppler-echocardiographic examination revealed that the left ventricles were neither dilated nor hypertrophied in all 3 groups . At baseline, the LV enddiastolic dimension (Ded) tended to increase from normal subjects The mitral inflow pattern was normal (E/A>1) in normal subjects , but inversed (E/A<1) in groups 1 and 2.
During dobutamine infusion, the LV chamber sizes , wall thickness, EF, E/ A of mitral inflow and rate-corrected isovolumic relaxation time (IVRTc) were similar among the 3 groups. During dobutamine infusion , Ded increased, endsystolic dimension (Des) decreased and endsystolic thickness (hes) significantly increased in normal subjects. This result correlated with the increase of EF from not improved significantly during dobutamine infusion although hes increased in groups 1 and 2, and Des decreased in group 2. The mitral inflow patterns were converted to normal (E/A>1) in groups 1 and 2 during dobutamine infusion . There were no regional wall motion abnormalities of LV at baseline and during and Vcfc, the cardiac contractility of diabetic patients was normal and had a tendency to be better than that of the normal subjects. However, during dobutamine infusion, the diabetic patients, especially in those patients with microvascular complications, revealed less increase of contractility shown by a lower Vcfc increment than normal subjects (Table III) . Higher resting EF in NIDDM patients without microvascular complications: At baseline, the diabetic patients tended to have a faster HR and a dilated left ventricle, though these data were not significantly different from those of the normal subjects. Patients without microvascular complications had higher EF than the normal subjects. This was probably because patients with NIDDM have hyperinsulinemia. Insulin can increase renal sodium retention19) and activate the sympathetic nervous system.20,21) Therefore, the cardiac performance of diabetic patients was maintained at normal levels or even higher in the basal condition. It failed to increase further on dobutamine infusion like normal subjects, indicating that the compensatory mechanisms at rest were already nearly fully activated. Well preserved resting contractility but inadequate reserve under stress conditions in NIDDM patients: By measuring the rate-corrected velocity of fiber shortening at various levels of end systolic wall stress, myocardial contractility can be evaluated without the influence of HR, preload and afterload . In this study, myocardial contractility was not significantly different among the normal subjects and the diabetic patients at baseline but had a tendency to increase in the diabetic patients, especially in those who had microvascular complications . Kimball et al.11) reported that in early onset IDDM (with a mean duration of 9 tractility was similar in IDDM and normal subjects. Nevertheless , Schwingshaudl reported that the increase in cardiac contractility in IDDM subjects was positively related to unfavorable metabolic control and higher insulin dose . It was therefore hypothesized that unphysiologically high peripheral exogenous insulin might have increased cardiac contractility. However , we found that the cardiac reserve, evaluated as Vcfc increment on dobutamine stimulation , was impaired in the diabetic patients, and worst in those patients with microvascular complications. considered that poorer metabolic control of diabetes and factors associated with obesity might explain the greater deterioration of LV systolic function in NIDDM than in IDDM. Our diabetic patients had a higher body mass index than normal subjects, though this did not reach a statistical significance. Ferraro14) also compared LV function in 2 types of DM and noted that plasma catecholamine levels were similarly elevated in both types. However, in IDDM, catecholamine may exert a direct positive inotropic effect; in NIDDM, compromised inotropic and lusitropic response to catecholamine was considered by Ferraro.14) This speculation remains to be verified.
Conclusion:
The NIDDM patients without other known heart diseases, despite being asymptomatic, still had impaired cardiac contractile reserve. The diastolic dysfunction in these patients developed earlier than systolic dysfunction, and the contractility at the basal state was well preserved in spite of microvascular changes. The overall cardiac performance in diabetic patients at the basal state may be better than in normal subjects, possibly through full activation of the sympathetic nervous system by elevated plasma insulin. However, the cardiac reserve was impaired rather earlier in NIDDM patients and became worse in those who had microvascular complications. Therefore, our results imply that it is a very important clinical issue to thoroughly control the diabetes, not only to prevent the development of microvascular complications but also to preserve cardiac function.
